Leads To Development

Leads To Development (L2D) was set up in 2009 to meet a relatively new opportunity in the biotech market – to allow companies to outsource the management and oversight of their preclinical drug development. Since then, L2D has rapidly built its reputation, expanded and strengthened its team, and broadened its services to encompass all non-clinical aspects of development as well as clinical oversight.

The company is now considered a leading expert and has a strong client base across Europe and the US to whom it provides hands-on scientific, regulatory and operational project management support across all stages of drug development.

L2D regularly recruits project managers to meet the company’s growth and therefore welcomes speculative applications. Joining their dynamic team is an amazing opportunity to make a difference. Using a team approach, you will help develop new drugs across many different types of therapies spanning a wide range of medical indications, for the patients who need them.

Their ideal candidates have a PhD in a biomedical subject or chemistry, a Dpharm, or other relevant qualification and an interest in new drug development and regulatory affairs.

They wish to recruit people who:

• Can demonstrate a genuine enthusiasm for drug development
• Have an outstanding level of spoken and written English and excellent communication skills
• Are analytical and meticulous
• Will enjoy both the operational aspects of drug development and writing technical or regulatory documents
• Flourish in a team environment and rise to meet challenges

Working for L2D also means enjoying:

• Modern bright well-equipped offices in the 15th arrondissement of Paris

• Health insurance

• Lunch vouchers (Bimpli card)

• Reimbursement of 50% of your travel card

• Organic locally grown fruit delivered to the office weekly

• Freshly ground coffee and 20 varieties of tea to choose from

• Home office up to 90 days per year if desired (after an office-based initiation period)

• Social values initiative